Preprint Open Access
Arumugham, Vinu
<?xml version='1.0' encoding='utf-8'?> <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#"> <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.2532167"> <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/> <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.2532167</dct:identifier> <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.2532167"/> <dct:creator> <rdf:Description> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <foaf:name>Arumugham, Vinu</foaf:name> <foaf:givenName>Vinu</foaf:givenName> <foaf:familyName>Arumugham</foaf:familyName> </rdf:Description> </dct:creator> <dct:title>Influenza and acellular pertussis vaccines not only fail to protect, they increase susceptibility and severity of disease upon infection – benefits are overrated and the risks are being ignored</dct:title> <dct:publisher> <foaf:Agent> <foaf:name>Zenodo</foaf:name> </foaf:Agent> </dct:publisher> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2019</dct:issued> <dcat:keyword>influenza</dcat:keyword> <dcat:keyword>vaccine</dcat:keyword> <dcat:keyword>pertussis</dcat:keyword> <dcat:keyword>mucosal immunity</dcat:keyword> <dcat:keyword>cell mediated immunity</dcat:keyword> <dcat:keyword>allergy</dcat:keyword> <dcat:keyword>asthma</dcat:keyword> <dcat:keyword>colonization</dcat:keyword> <dcat:keyword>linked epitope suppression</dcat:keyword> <dcat:keyword>Th2</dcat:keyword> <dcat:keyword>aluminum adjuvant</dcat:keyword> <dcat:keyword>multiple sclerosis</dcat:keyword> <dcat:keyword>autism</dcat:keyword> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2019-01-05</dct:issued> <owl:sameAs rdf:resource="https://zenodo.org/record/2532167"/> <adms:identifier> <adms:Identifier> <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/2532167</skos:notation> <adms:schemeAgency>url</adms:schemeAgency> </adms:Identifier> </adms:identifier> <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.2532166"/> <dct:description><p>The influenza vaccine fails often. The influenza vaccines cause the development of IgE mediated<br> allergy to the influenza virus. The reason for failure include antigenic mismatch between vaccine strain<br> and wild virus, IgE mediated antigen neutralization, etc. Naturally acquired immunity against influenza<br> lasts for decades. Vaccine based immunity lasts for a few months. Replacing natural immunity with<br> vaccine-based immunity, progressively increases susceptibility over time. In 2016-18, between 46 and<br> 68% of patients admitted to the ICU for severe influenza were vaccinated with the influenza vaccine, in<br> California. The influenza vaccine uptake in the general population in California during that same period<br> was between 40-48%. This adds to evidence that not only does the influenza vaccine fail, it can<br> contribute to increased disease severity. The increase in disease severity is due to patients suffering an<br> allergic reaction against the virus, concurrent with the influenza infection.<br> The acellular pertussis vaccine (APV) fails to protect for more than a year in most patients, fails to<br> provide mucosal immunity, fails to provide cell mediated immunity and fails to protect against airway<br> colonization with Bordetella pertussis (BP) bacteria. Therefore the APV causes asymptomatic<br> spreading of BP. The exact opposite effect of herd immunity - herd spreading. The APV causes IgE<br> mediated sensitization directed against BP antigens. Therefore once colonized, continuing exposure to<br> BP antigens results in asthma. Colonization with BP can cause multiple sclerosis. The APV contains<br> cow&rsquo;s milk proteins used to manufacture the vaccine. The milk proteins include bovine casein, bovine<br> insulin and bovine folate receptor proteins. The result is the development of milk allergy, type 1<br> diabetes and autism respectively. Colonization can induce immune tolerance to BP, making an infection<br> even more dangerous and rendering the patient potentially unprotectable for life with a future pertussis<br> vaccine.</p> <p>&nbsp;</p></dct:description> <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/> <dct:accessRights> <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess"> <rdfs:label>Open Access</rdfs:label> </dct:RightsStatement> </dct:accessRights> <dcat:distribution> <dcat:Distribution> <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/> <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.2532167"/> </dcat:Distribution> </dcat:distribution> <dcat:distribution> <dcat:Distribution> <dcat:accessURL>https://doi.org/10.5281/zenodo.2532167</dcat:accessURL> <dcat:byteSize>59314</dcat:byteSize> <dcat:downloadURL>https://zenodo.org/record/2532167/files/flupertJan5.pdf</dcat:downloadURL> <dcat:mediaType>application/pdf</dcat:mediaType> </dcat:Distribution> </dcat:distribution> </rdf:Description> </rdf:RDF>
All versions | This version | |
---|---|---|
Views | 2,022 | 2,023 |
Downloads | 507 | 507 |
Data volume | 30.1 MB | 30.1 MB |
Unique views | 1,856 | 1,857 |
Unique downloads | 453 | 453 |